Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02406079
Other study ID # CZ-001
Secondary ID
Status Completed
Phase N/A
First received March 25, 2015
Last updated April 1, 2015
Start date January 2013
Est. completion date March 2014

Study information

Verified date April 2015
Source First People's Hospital of Chenzhou
Contact n/a
Is FDA regulated No
Health authority China: Ministry of Science and Technology
Study type Interventional

Clinical Trial Summary

Procalcitonin (PCT) is a reliable biomarker of infection and sepsis. The investigators aimed to determine whether tracheotomy influences PCT concentrations in patients without sepsis, and to assess whether operative duration and procedure affect the peak PCT level.


Description:

Read more »
Read more »

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening


Related Conditions & MeSH terms


Intervention

Procedure:
tracheotomy
Tracheotomy is one of most performed surgical procedures to assure airway by making a hole in front of the trachea in ICU.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
First People's Hospital of Chenzhou

Outcome

Type Measure Description Time frame Safety issue
Primary procalcitonin 0-72 hours No
See also
  Status Clinical Trial Phase
Withdrawn NCT02977767 - Evaluation of the Effect of Conversational Hypnosis When Changing Tracheal Cannula in Adult Patients N/A
Completed NCT01793363 - Tracheostomy and Weaning From Mechanical Ventilation : Evaluation of the Lung Ultrasound Score N/A
Completed NCT04041817 - Pulmonary and Ventilatory Effects of Trigger Modulation in Intubated ICU N/A